The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV 1 /FVC for the Diagnosis of Airway Limitation in Inadequate Spirometry

Abstract

BACKGROUND:

Spirometry is important for the differential diagnosis of dyspnea. However, some patients cannot exhale for ≥6 s to achieve the American Thoracic Society/European Respiratory Society criteria. The aim of this study was to demonstrate the reliability of a new parameter that quantifies the degree of concavity in the first 3 s to define airway limitation as a surrogate for the FEV₁/FVC.

METHODS:

Four hundred spirometry test results were selected through complete random sampling. The new parameter, termed the AUC₃/AT₃, was calculated as the area under the descending limb of the expiratory flow-volume curve before the end of the first 3 s (AUC₃) divided by the area of the triangle before the end of the first 3 s (AT₃). The AUC₃/AT₃ was compared with the FEV₁/FVC using Pearson's correlation analysis. The level of agreement between the AUC₃/AT₃ and the FEV₁/FVC in the detection of airway obstruction was analyzed using the kappa statistic. We also compared the diagnostic accuracy of the new index with that of the FEV₁/forced expiratory volume in the first 3 s (FEV₃).

RESULTS:

There was a strong correlation (r = 0.88, P < .001) between the AUC₃/AT₃ and the FEV₁/FVC. There was also strong agreement between the AUC₃/AT₃ and the FEV₁/FVC in the detection of obstruction with kappa indices of 0.72 (Global Initiative for Chronic Obstructive Lung Disease [GOLD] criterion) and 0.67 (lower limit of normal criterion), and these values were greater than those obtained for the FEV₁/FEV₃. The AUC₃/AT₃ also exhibited acceptable sensitivity, specificity, positive predictive value, and negative predictive value. The diagnostic accuracies of the AUC₃/AT₃ were 86.3% (GOLD criterion) and 83.8% (lower limit of normal criterion), which were greater than the 76.0 and 74.0% obtained for the FEV₁/FEV₃, respectively.

CONCLUSIONS:

The AUC₃/AT₃ can be utilized as a surrogate parameter for the FEV₁/FVC when patients cannot complete a 6-s expiratory effort. Additionally, the performance of this index is better than that of the FEV₁/FEV₃ in the identification of airway limitations.

Keywords

respiratory function tests spirometry airway obstruction maximal expiratory flow-volume curves area under the curve diagnosis

Get full access to this article

View all access options for this article.

References

Pellegrino

, Viegi

, Brusasco

, Crapo

, Burgos

, Casaburi

, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005; 26(5):948–968.

Miller

, Hankinson

, Brusasco

, Burgos

, Casaburi

, Coates

, et al. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338.

Eaton

, Withy

, Garrett

, Mercer

, Whitlock

, Rea

. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest, 1999; 116(2):416–423.

Allen

, Yeung

, Janczewski

, Siddique

. Predicting inadequate spirometry technique and the use of FEV₁/FEV₃ as an alternative to FEV₁/FVC for patients with mild cognitive impairment. Clin Respir J, 2008; 2(4):208–213.

Lutfi

. Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma. Int J Appl Basic Med Res, 2011; 1(1):20–23.

Ioachimescu

, Venkateshiah

, Kavuru

, McCarthy

, Stoller

. Estimating FVC from FEV₂ and FEV₃: assessment of a surrogate spirometric parameter. Chest, 2005; 128(3):1274–1281.

Townsend

, Du Chene

, Fallat

. The effects of underrecorded forced expirations on spirometric lung function indexes. Am Rev Respir Dis, 1982; 126(4):734–737.

Mehrparvar

, Rahimian

, Mirmohammadi

, Gheidi

, Mostaghaci

, Lotfi

. Comparison of FEV₃, FEV₆, FEV₁/FEV₃ and FEV₁/FEV₆ with usual spirometric indices. Respirology, 2012; 17(3):541–546.

Wildhaber

, Sznitman

, Harpes

, Straub

, Möller

, Basek

, Sennhauser

. Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flow-volume curves. Respir Care, 2007; 52(12):1744–1752.

10.

Majak

, Cichalewski

, Ożarek-Hanc

, Stelmach

, Jerzyńska

, Stelmach

. Airway response to exercise measured by area under the expiratory flow-volume curve in children with asthma. Ann Allergy Asthma Immunol, 2013; 111(6):512–515.

11.

Zapletal

, Hladíková

, Chalupová

, Svobodová

, Vávrová

. Area under the maximum expiratory flow-volume curve: a sensitive parameter in the evaluation of airway patency. Respiration, 2008; 75(1):40–47.

12.

Seppälä

. Reproducibility of methacholine induced bronchoconstriction in healthy subjects: the use of area under the expiratory flow-volume curve to express results. Respir Med, 1990; 84(5):387–394.

13.

Lee

, Lee

, Cho

, Park

, Oh

, et al. Graphic analysis of flow-volume curves: a pilot study. BMC Pulm Med, 2016; 16:18.

14.

Quanjer

, Stanojevic

, Cole

, Baur

, Hall

, Culver

, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J, 2012; 40(6):1324–1343.

15.

Mohamed Hoesein

, Zanen

, Lammers

. Lower limit of normal or FEV₁/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med, 2011; 105(6):907–915.

16.

Wollmer

, Engström

. Fixed ratio or lower limit of normal as cut-off value for FEV₁/VC: an outcome study. Respir Med, 2013; 107(9):1460–1462.

17.

Arkin

, Wachtel

. How many patients are necessary to assess test performance?. JAMA, 1990; 263(2):275–278.

18.

Kapp

, Schachter

, Beck

, Maunder

, Witek

Jr . The shape of the maximum expiratory flow volume curve. Chest, 1988; 94(4):799–806.

19.

Schachter

, Kapp

, Maunder

, Beck

, Witek

. Smoking and cotton dust effects in cotton textile workers: an analysis of the shape of the maximum expiratory flow volume curve. Environ Health Perspect, 1986; 66:145–148.

20.

Omland

, Sigsgaard

, Pedersen

, Miller

. The shape of the maximum expiratory flow-volume curve reflects exposure in farming. Ann Agric Environ Med, 2000; 7(2):71–78.

21.

Kraan

, van der Mark

, Koëter

. Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids. Thorax, 1989; 44(12):1015–1021.

22.

Mead

. Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol, 1978; 44(2):156–165.

23.

Vermaak

, Bunn

, de Kock

. A new lung function index: the area under the maximum expiratory flow-volume curve. Respiration, 1979; 37(2):61–65.

24.

Trzaska-Sobczak

, Pierzchala

. [Prediction of exercise capacity in chronic obstructive pulmonary disease patients on the basis of maximum expiratory flow-volume curve]. Pneumonol Alergol Pol, 2007; 75(3):213–218.

25.

Struthers

, Addis

. Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patients. Eur J Clin Pharmacol, 1988; 34(3):277–281.

26.

Kawamoto

, Kimura

, Kambe

, Miyamura

, Kuraoka

. [Significance of area under the flow volume curve: useful index of bronchial asthma]. Arerugi, 1999; 48(7):737–740.